【结 构 式】 |
【分子编号】25196 【品名】[1-(2-methoxyphenyl)-4-piperidinyl]methylamine; [1-(2-methoxyphenyl)-4-piperidinyl]methanamine 【CA登记号】 |
【 分 子 式 】C13H20N2O 【 分 子 量 】220.31468 【元素组成】C 70.87% H 9.15% N 12.72% O 7.26% |
合成路线1
该中间体在本合成路线中的序号:(VII)Condensation of isonicotinamide (I) with 1-chloro-2,4-dinitrobenzene (II) gave quaternary pyridinium salt (III). This was further converted into pyridinium salt (V) by treatment with 2-methoxyaniline (IV) in MeOH. Catalytic transfer hydrogenation of the pyridine ring of (V) provided piperidine (VI). The amide function of (VI) was then reduced to amine (VII) using either borane-dimethyl sulfide complex or LiAlH4. Condensation of 4-chlorocatechol (VIII) with epichlorohydrin (IX) in aqueous KOH produced a mixture of regioisomeric benzodioxans (X) and (XI), from which the major 7-chloro isomer (X) was isolated by flash chromatography after treatment with tosyl chloride and pyridine yielding tosylate (XII). This compound was finally coupled with amine (VII) in the presence of K2CO3 and KI in boiling acetonitrile.
【1】 Kerrigan, F.; Heal, D.J.; Martin, K.F. (The Boots Company plc); Bicyclic aromatic cpds. as therapeutic agents. EP 0717739; JP 1997502431; US 5767116; WO 9507274 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 25191 | isonicotinamide | 1453-82-3 | C6H6N2O | 详情 | 详情 |
(II) | 10378 | 1-Chloro-2,4-dinitrobenzene | 97-00-7 | C6H3ClN2O4 | 详情 | 详情 |
(III) | 25192 | 4-(aminocarbonyl)-1-(2,4-dinitrophenyl)pyridinium chloride | 475-25-2 | C12H9ClN4O5 | 详情 | 详情 |
(IV) | 25193 | 2-methoxyphenylamine; 2-methoxyaniline | 517-28-2 | C7H9NO | 详情 | 详情 |
(V) | 25194 | 4-(aminocarbonyl)-1-(2-methoxyphenyl)pyridinium chloride | C13H13ClN2O2 | 详情 | 详情 | |
(VI) | 25195 | 1-(2-methoxyphenyl)-4-piperidinecarboxamide | C13H18N2O2 | 详情 | 详情 | |
(VII) | 25196 | [1-(2-methoxyphenyl)-4-piperidinyl]methylamine; [1-(2-methoxyphenyl)-4-piperidinyl]methanamine | C13H20N2O | 详情 | 详情 | |
(VIII) | 25197 | 4-chloro-1,2-benzenediol | 2138-22-9 | C6H5ClO2 | 详情 | 详情 |
(IX) | 10146 | Epichlorohydrin; 2-(Chloromethyl)oxirane | 106-89-8 | C3H5ClO | 详情 | 详情 |
(X) | 25199 | (7-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methanol | C9H9ClO3 | 详情 | 详情 | |
(XI) | 25198 | (6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methanol | C9H9ClO3 | 详情 | 详情 | |
(XII) | 25200 | (7-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methyl 4-methylbenzenesulfonate | C16H15ClO5S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VII)The reaction of 5-chloro-2-hydroxybenzaldehyde (I) with the chiral glycidyl tosylate (II) by means of K2CO3 in DMF gives the condensation product (III), which is oxidized with m-chloroperbenzoic acid to formyl ester (IV). The cyclization of (IV) with sodium methoxide in methanol affords the hydroxymethyl benzodioxane (V), which is tosylated with tosyl chloride in pyridine to the tosylate (VI). Finally, this compound is condensed with 1-(2-methoxyphenyl)piperidin-4-ylmethylamine (VII) by means of K2CO3 in refluxing acetonitrile.
【1】 Birch, A.M.; Needham, P.L.; Kerrigan, F.; Gill, J.C.; Bradley, P.A.; N-substituted (2,3-dihydro-1,4-benzodioxin-2-yl)methylamine derivatives as D2 antagonists/5HT1A partial agonists with potential as atypical antipsychotic agents. J Med Chem 1999, 42, 17, 3342. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26408 | 5-chlorosalicylaldehyde; 5-chloro-2-hydroxybenzaldehyde | 635-93-8 | C7H5ClO2 | 详情 | 详情 |
(II) | 16242 | (2R)oxiranylmethyl 4-methylbenzenesulfonate; (2R)-(-)-Glycidyl tosylate | 113826-06-5 | C10H12O4S | 详情 | 详情 |
(III) | 26409 | 5-chloro-2-[(2R)oxiranylmethoxy]benzaldehyde | C10H9ClO3 | 详情 | 详情 | |
(IV) | 26410 | 5-chloro-2-[(2R)oxiranylmethoxy]phenyl formate | C10H9ClO4 | 详情 | 详情 | |
(V) | 26411 | [(2S)-7-chloro-2,3-dihydro-1,4-benzodioxin-2-yl]methanol | C9H9ClO3 | 详情 | 详情 | |
(VI) | 26412 | [(2R)-7-chloro-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate | C16H15ClO5S | 详情 | 详情 | |
(VII) | 25196 | [1-(2-methoxyphenyl)-4-piperidinyl]methylamine; [1-(2-methoxyphenyl)-4-piperidinyl]methanamine | C13H20N2O | 详情 | 详情 |